Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer
NCT00004236
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
OTHER
Sponsor class
Conditions
Esophageal Cancer
Gastric Cancer
Interventions
DRUG:
pegylated liposomal doxorubicin hydrochloride
Sponsor
University of Leicester